Expression of CD34 on human B cell precursors

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• CD34 is a key glycoprotein marker for immature hematopoietic cells.
• Characterizing CD34+ cell subpopulations is crucial for understanding hematopoiesis and leukemia.
• Previous limitations in direct fluorochrome labeling of anti-CD34 antibodies hindered detailed subpopulation analysis.

Purpose of the Study:

• To characterize the reactivity of a novel directly fluorochrome-labeled anti-CD34 monoclonal antibody (mAb), 8G12.
• To compare 8G12 with the established My10 anti-CD34 mAb.
• To analyze normal early human B cell precursors and identify specific cell populations.

Main Methods:

• Isolation and direct fluorochrome labeling of the murine anti-CD34 mAb 8G12.
• Multi-parameter flow cytometry (two- and three-color immunofluorescence analysis).
• Comparison of 8G12 and My10 reactivity on normal and leukaemic human bone marrow and blood cells.

Main Results:

• The reactivity patterns of 8G12 and My10 were indistinguishable on normal and leukaemic hematopoietic cells.
• Both antibodies identified a CD34+CD10+CD19- population in normal adult bone marrow.
• Further analysis indicated that all CD34+CD10+ cells in adult bone marrow co-expressed CD19, with no detectable CD34+CD10+CD19- population.

Conclusions:

• The directly labelable anti-CD34 mAb 8G12 is a valuable tool for multi-parameter flow cytometry.
• 8G12 and My10 exhibit similar reactivity, confirming their utility in identifying hematopoietic cell populations.
• The absence of a significant CD34+CD10+CD19- population in adult bone marrow suggests developmental differences compared to fetal liver.